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Innovative PET Camera
Readied for Tumor
Detedion Trials

Dr. Wai-Hoi (Gary) Wong woks out through the MDACAM, a
prototype PET camera deuewped for /,ow-cost, high-resolution tumor
imagi,ng. It has the highest resolution (2. 8 mm) of any whol.e-body PET
camera in existence, according to Dr. Wong, whose work is supported
by grants from the National Institutes of Health and others. Design
al/,ows horizontal or vertical scanning and an adjustabl.e ojJening to
accommodate a singl.e breast or an entire body.
(see page 2)

High Resolution, High Sensitivity,
and Variable Field of View Set MDACAM Apart
( Continued from page 1)

by Stephanie Deming

very year in the United States, more
than 400, 000 women have so-called
unnecessary breast biopsies-biopsies
of lesions that are suspicious on
mammography but turn out to be
benign. Most of these "unnecessary" biopsies could
be avoided ifpositron emission tomography (PET)
became part of the diagnostic algorithm for breast
cancer, according to Wai-Hoi (Gary) Wong,
Ph.D., director of instrumentation development
for the Department of Nuclear Medicine at The
University of Texas M. D. Anderson Cancer Center.
Developing a high-resolution,
high-sensitivity PET camera uniquely
suited to breast imaging has been
Dr. Wong's aim for the last four years,
and soon he hopes to begin testing
his camera, the MDACAM, in the
clinical setting.
PET, said Dr. Wong, has the
potential to rule out breast cancer in
patients with suspicious findings on
mammography. With mammography,
he explained, the contrast differential
between less dense normal tissue and
denser tumor tissue is about 1 % to
2%-thus the difficulty of detecting
tumors and the high number of
suspicious mammographic findings
that require confirmation with biopsy.
e con ras 1 eren 1a is
improved somewhat with digital
mammography, a technique currently under review by the Food and
Drug Administration, but according
to Dr. Wong, "digital mammography
has a larger dynamic range than
film, but it's still just mammography,
which images density differentials."
With PET, however, the contrast
differential between tumor and
normal tissue is dramatic, thanks
to PET's imaging of physiologic
function rather than density. "For
tumor applications," explained
Dr. Wong, "you try to inject anything
2 / MD Anderson OncoLog

In tests of the MDA CAM using a phantom 1Yreast, Dr.
Wong produced these axial images of a breast 11. 43 cm
(4.5 inches) in diameter (left) and one 15.24 cm (6
inches) in diameter (right). L esions were ( clockwise,
beginning at 12 o'clock) 3 mm, 4 mm, 5 mm, and 6 mm.

that differentiates the tumor from
normal tissue."
Taking advantage of the fact
that breast tumors metabolize more
glucose than normal breast tissue,
Dr. Wong and his team have been
using fluorodeoxyglucose (FOG),
whose uptake in tumors is between
3 and 20 times its uptake in normal
tissue, creating a contrast differential
of 300% to 2,000%.
PET's cost-about $1,500 to
$2,000 per scan-makes PET unlikely
to become the first-line screening
examination for breast cancer for
all women; however, Dr. Wong hopes
that PET will replace biopsy as the
standard examination in women with
a susp1c1ous m mg on mammography. But PET may be the method of
choice for first screening for women
at high risk and women with silicone
implants.
"Last year, there were about
600,000 breast biopsies, and 400,000
of those lesions were not malignant,"
he said, "so two thirds of those biopsies
were unnecessary. Those are the
statistics year after year. But if we put
PET in the middle and eliminate, let's
say, 80% of those unnecessary biopsies, we save 320,000 biopsies a year."
Were PET substituted for biopsy,
women would be spared an invasive

procedure, and Dr. Wong estimates
the cost of scans by his machine
would be comparable with or less than
the cost of some biopsy procedures.
Supported by more than $3.5
million in grants from the National
Institutes of Health and the Texas
Higher Education Commission,
Dr. Wong and his group have spent
the past four years developing a
prototype PET camera that offers
several advantages over commercially
available cameras.
First, the MDACAM has a unique,
patented detector design that greatly
improves the image resolution. "The
detector in my m achine is about one
quarter of the size of [ the detector
m a commerc1a mac me,' said Dr.
Wong. "That allows us to find much
smaller tumors. We can see 3-mm
tumors very well." With the prototype
camera, Dr. Wong said, "you can
differentiate whether it is singlelesion or multilesion disease. In the
case of a lower resolution camera,
two nearby tumors probably would
look like one."
Ronald Nutt, Ph.D., senior vice
president and technology director
of CTI, Inc. , which makes commercial PET cameras, has followed Dr.
Wong's work over the past decade
and views this innovative detector
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a benign biopsy is not a benign experiencefor the woman.,,

- Wai-Hoi Wong, Ph.D., Department of Nuclear Medicine

i

design as "one of the breakthroughs
that is very important to PET imaging."
The second advantage of
MDACAM is its lower cost, which is
also a function of the unique detector design. "This design allows me
to keep the cost lower than commercial tomographs," said Dr. Wong.
"We expect that this camera will have
a production cost of only 60% of a
regu lar machine."
The third advantage of the prototype camera is what Dr. Wong calls
its "convertible geometry." Unlike
com mercially available PET cameras,
in which the patient lies on a table
that slides through a vertical opening, the prototype machine can be
tilted so that the camera opening can
be set to either vertical or horizontal.
"The machine that I developed
here has a special breast mode," said
Dr. Wong. "The patient lies on top
of the camera with the breast hanging down. In a regular commercial
machine, the chest is inside the
camera and the chest attenuates
the majority of the signal. By having
the breast hanging down and only
the breast in the field of view of the
cam era, I can get eight times higher
detection sensitivity." The patient
opening in the camera can also be
adju sted to any diameter between

32 and 55 cm. "With the small-ring
configuration," Dr. Wong said,
"the detector module is placed
very near the breast, which also
increases sensitivity."
Plans are under way to begin
testing the new camera in clinical
trials. In these trials, patients will
have scans with both Dr. Wong's
camera and a commercially available
PET camera, and the results will
be compared. The new camera
will also be used for other imaging
applications, including brain,
head and neck, and whole-body
imaging.
"All the advantages true for
the breast will be true for brain
tumors, for head and neck tumors,"
said Dr. Wong, citing the size
similarity between brain and
breast.
Use of PET remains somewhat
limited at present, in large part
because of financial considerations.
According to Dr. Nutt, the major
challenge to widespread implementation of PET is reimbursement
regulation. The Health Care Financing Administration (HCFA), which
administers the Medicare and
Medicaid programs within the U.S.
Department of Health and Human
Services, only recently approved

reimbursement for a PET application for the first time-detection of
lung cancer-but more approvals
appear to be on the horizon.
"There's a major effort going
on in HCFA to have a broad-based
reimbursement for PET for most all
oncology indications," Dr. Nutt said.
"This is probably the most important
milestone for PET to become really
widespread." HCFA sponsored town
hall meetings in January to hear
arguments for PET oncology application reimbursement. Other hurdles
to overcome are the limited number
of sites that produce the radiopharmaceuticals required for PET
and the high cost of the cameras. "I
look forward to Gary Wong's getting
his tomograph in the clinical environment," Dr. Nutt said, "and I
would say the super-high resolution
he's got will pave the way for industries such as ours to bring forth
commercial versions that will be
very valuable in PET, especially in
things like breast cancer."
Dr. Wong is hopeful this will
occur soon. "After all," he said,
"a benign biopsy is not a benign
experience for the woman." •
FOR MORE INFORMATION,

contact Dr. Wong

at (713) 745-3069.
A three-dimensional
image of the same
phantom breasts
pictured on page 2
shows peaks at the
lesion sites proportionate to glucose
uptake.
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aTheIMultidimensional Side Effed
by Sunni Hoseman and Beth W. Allen

or some people,
fatigue means
needing rest after
exercise or a long
day at work. For cancer
patients, it means not feeling
strong enough to move from
room to room and not being
able to eat.

F

Labeled by some as cancer's
number one side effect, fatigue is
part of the illness of 72%-95% of
patients with cancer. Chronic or
acute-some describe it as "hitting
a wall "-the fatigue experienced
by patients with cancer differs from
that of healthy people. According
to Carmen Escalante, M.D., it is
debilitating and depressing, it
interferes with normal activities,
and it is a barrier to a person's
enjoyment of life. The National
Cancer Institute describes fatigue's
social implications as potentially
"profound."
Fatigue, long discounted, has
become more prominent because
therapies have become more aggressive and exacerbatedi-rand b-ecause~
health professionals have acknowledged it as a dose-limiting toxicity
of therapy and as a quantifiable and
treatable side effect. It is emerging
as a serious topic of research,
which encompasses biochemical,
pathophysiologic, psychologic,
and behavioral variables.
An internal medicine specialist,
Dr. Escalante is one of two physicians
at The University of Texas M. D.
Anderson Cancer Center heading the
newly opened Fatigue Clinic. They, as
internal medicine specialists, manage
such complications as anemia and
comorbid conditions such as diabetes,
while, as she says, "the oncologists take
4 / MD Anderson OncoLog

care of the cancer." Tejpal Grover,
M.D., also serves the clinic.
Fatigue is related most often to
treatment rather than to cancer,
but that does not mean it ends when
tre-atment ends~he tumor'stheft
of nutrients, a hypermetabolic state
related to tumor growth, infection,
and disruption of cellular processes
also account for fatigue. In many
patients, the fatigue persists for
months after treatment's conclusion.
"By that time," says Bethjohnson,
R.N., senior research nurse with
M. D. Anderson's Pain Research
Group and the clinic's nurse, "the
sympathy and support patients have
had during the activ phas of their
illness is gon or diminish d, and
they are expected to be back and
functioning. It's much harder for
them to keep saying they don't
have the energy."

The study of fatigue was a natural
extension of the work of the Pain
Research Group and its head,
Charles Cleeland, Ph.D ., who conducts international pain studies.
These researchersuesigned and
validated the Brief Fatigue Inventory,
a scale the clinic uses to quantify
patients' experience of fatigue.
A professor in the Division of Anesthesiology and Critical Care, Dr.
Cleeland is part of the team
coordinating the clinic's operation.
'We definitely find fatigue problems are worse when pain control is
inadequate," Dr. Escalante says. "In
fact, some of our most impressive
r sults to date simply resulted from
pain reduction."
Dr. Cleeland calls the patient's
r port "the gold standard" in evaluating fatigue and its costs. Using a 0-10
cale, the inventory includes mea-

Labeled by some as cancer's number one side ejfed,
fatigue is part of the illness of 72%-95%
of patients with cancer.
sures of fatigue's constancy, duration,
time pattern, and effect on normal
daily activities and quality of life.
The inventory is similar to one Dr.
Health professionals can find additional information about cancer-related
Cleeland previously devised for pain
on the World Wide Web. Below are two recommended sites:
fatigue
that is now used internationally.
Daily phone calls are also used to
http://cancernet.nci.nih.gov/clinp dq/supportive /Fatigue _Phys ician.html
assess a patient's fatigue and the
The National Cancer Institute sponsors PDQ, a 1.3 million-record
effectiveness of interventions.
database, which includes this review of fatigue. Part of the Health Profes
At initial workup, Dr. Escalante's
sionals Supportive Care and Advocacy Issues section, the report includes
aim is to define the severity of fatigue
the following topics: overview, fatigue factors, assessment, intervention,
and determine its relationship to
and posttreatment considerations. Each section includes bibliographical
physiologic variables. The assessment
references.
includes taking a history, performing
http://oncolink.upenn.edu/tv/conference/suf/
a physical examination, and identify
The University of Pennsylvania's popular OncoLink site offers video segments
ing such underlying or comorbid
from its conference "National Cancer Fatigue Awareness Week: Stand Up to
conditions as anemia, metabolic
Fatigue." Site visitors can select from presentations by physicians and nurses.
disorders, eletrolyte imbalances,
Topics include "Anemia: A Reversible Cause of Cancer-related Fatigue," "Link
and low nutritional status. Of course,
of Nutrition to Cancer Fatigue," and "Exercise to Treat Cancer Fatigue." A
low hemoglobin and albumin levels
link to free software to play the segments is provided.
correlate directly with fatigue, and
such disease processes as chronic
obstructive pulmonary disease can
exacerbate it. Because pain, depres
feel like eating. Although there is
sion, and sleep disorders are inter
evidence that mild exercise, like
twined and because all can produce
walking, is helpful in combating
eating dysfunction, these too are
not only fatigue but also depression,
measured and their contribution to
many patients need some coaching
the patient's exhaustion evaluated.
on how to exercise when physicial
Clinical Nurse Specialist Deborah
activity seems beyond their ability.
Thorpe, Ph.D., R.N., C.S., incorpo
Drugs can also help patients manage
rates evaluation of fatigue in her
anemia.
work in the M. D. Anderson Pain
Rehabilitation, occupational,
Carmen Escalante, M.D. Tejpal Grover, M.D
Clinic. "Fatigue is even more preva
and physical therapists are at times
research, and education in fatigue.
lent than pain," she said. "It is the
consulted for modifications to rouThe program sponsors meetings
number one complaint of patients
tine activities of daily living that help
and educational sessions for patients
with cancer." Dr. Thorpe's work
conserve energy. A rolling stool in
encompasses the association between and health care professionals and last the kitchen, a seat in the shower, a
pam m tensicy;f;:rtigffe-;-arrd-sl-eep
· ear-e stabJished--a-Fat:igt1:e-Awareness--r0Hing-walk-er-for-supp0r-t,an0.-•a----+-patterns, and she has been collecting Week, to be held each April to bring
person to help with daily chores
attention to fatigue problems and
data and performing some analyses
are solutions that patients with
solutions.
of fatigue severity in patients seen in
fatigue find useful.
Begun six months ago, the
the Pain Clinic. She was also part of
Such nonpharmacologic interventhe team involved in initial planning
Fatigue Clinic is open two half days
tions as relaxation exercises, meditaper week and draws on members
for the Fatigue Clinic.
tion, and self-hypnosis are also used
of many disciplines for consultation.
She points to a cooperative
to help patients to relieve stress and
It is expected to expand to full-time
program between Ortho Biotech,
better cope with fatigue, according
operation.
Inc., and the Oncology Nursing
to Dr. Thorpe.•
Many patients need a nutritionist
Society called FIRE (Fatigue Initia
to help them plan meals that will
tive through Research and Educa
FOR MORE INFORMATION, please contact Beth
inspire them to eat when they don't
tion) as helping spur interest,
Johnson at (713) 745-2934.

Internet Sites Promote Fatigue Awareness
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Community Physidans:
Important Partners With M. D. Anderson
t the The University of Texas M. D. Anderson Cancer
~ Center, the Office ofReferral Rel.ations, l,ed by codirectors Lewis
~
Foxhall, M .D., and Richard Babaian, M .D., works to
.J. _ _ L strengthen relations between physicians and the institution.
"This program sustains the idea
that physicians in the community
are important partners with the
institution," explains Dr. Foxhall,
who is also associate vice president
of health policy. "There has always
been an intent and an interest in
nuturing that relationship."
Important among those efforts
are the almost 2,000 office visits
four Referral Relations physician
relations coordinators make every
year. Traveling more than 200 miles
east, north, and west of Houston,
they provide information about
M. D. Anderson programs and seek
to answer any questions physicians
have about the referral process and
interaction with the cancer center.
For physicians beyond this radius,
the coordinators use phone, fax,
and E-mail to provide information
and to keep in contact.
Admission for evaluation or
treatment of cancer makes hospitalization "more challenging and
difficult," said Dr. Foxhall, especially
when, for example, a child is admitted. "Stress, anxiety, and emotional
and financial problems may be
compounded," he said, emphasizing
the importance of a good start.
That good start begins at the
New Patient Referral Office, which
Dr. Babaian serves as medical director.
Coordinating this office is Belinda
Weatherly, director of patient access
services. Working with her in teams
are nurses who assist physicianreferred and self-referred patients
through registration, admitting,
and financial clearance and then
triage them to the appropriate
service. Across the continuum of
care, Dr. Babaian says, the aim is to
partner with the referring physicians
and to ensure they get the information they need, especially if they are
6 / MD Anderson OncoLog

providing outpatient or follow-up
care.
Before or during treatment, the
physician relations coordinators can
provide referral assistance fax forms,
financial assistance forms , Texas
Medical Center maps, brochures on
specific programs and departments,
a new patient orientation video,
information on M. D. Anderson's
patient support group, information
on protocols, and many other
types of information. Referral
Relations staff also assist in resolving
complaints, billing questions, and
follow-up questions, and such cases
are reviewed monthly with the
physician-in-chief.
Complementing the liaison
function of Referral Relations are
ad hoc advisory panels. 'With these
panels, " Dr. Babaian said, ''we are
trying to improve the process, increase
communication between Anderson
physicians and community physicians,
and get input on our operations that
will help us enhance services beginning at the front door." A formal
panel, the Executive Advisory Panel,
made up of officers from state and
local medical organizations, functions
as a forum for exchange of ideas
regarding health policy.
'We are very proactive in seeking
out physicians' opin ions," Dr. Babaian
said, explaining that the institution
is learning how to make itself more
"user friendly" from data collected
from surveys and referrals.
A second important focus of
Referral Relations, according to
Dr. Foxhall, is its community-based
educational programs. Last year
more than 750 medical professionals
attended education events organized
by Referral Relations and supported
by the speakers bureau composed of
M . D. Anderson faculty. Local

community hospitals are typical
sites for such physician-requested
programs.
A single comprehensive edu cational event held annually is Primary
Care for the 90's, a seminar series
jointly sponsored by M. D. Anderson,
The University of Texas Medical
School Department of Family Practice, and the Texas Academy of
Family Physicians. M. D. Anderson
faculty contribute presentations on
prevention, diagnosis, and treatment
for breast, cervix, colon, lung, prostate, and skin cancer. In recognition
of his statewide leadership in launching and broadening the program,
Dr. Foxhall last summer received the
Texas Academy of Family Physicians'
President's Award.
Briefly, other programs supported
by the Office of Referral Relations
include M. D. Anderson Associates,
an organization of former facul ty and
physicians who trained at the institution, and the Texas Cancer Data
Center, which serves as a clearinghouse of cancer-related data, now
accessible on the World Wide Web
at http: / / www.txcancer.org.
Referral Relations also publishes
and distributes a biennial clinical
staff directory and regularly supplies
exhibits at annual meetings of
professional organizations, including
the American College of Surgeons,
the American Society of Clinical
Oncologists, and the Texas Medical
Association.
Dr. Foxhall says that there are
physicians who, after working with
Referral Relations or attending a
seminar, get involved by, for example,
organizing programs themselves in
the community. "It's gratifying," he
says, "to see the cycle of partnersh ip
continue."
Physicians are encouraged to
con tact a physician relations coordinator at (713) 792-2200 or (800) 2520502 for information about referrals
or continuing education activities, or
to resolve questions before, during,
or after a patient's visit. •
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How to Talk With Your Dodor
ew experiences can be as devastating as learning that you
have cancer or any other life-threatening disease. At a time
when you are likely to feel overwhelmed and vulnerable,
you 're suddenly faced with obtaining important information from your doctor and understanding complicated medical
terms. Here are a few tips to make that often-difficult process
easier and help you to get what you need from your doctor.
• Make a list of all your questions
before you see your doctor.
After writing each question, leave
room underneath to write down
the answers.

• Bring a friend or family member
with you to your appointments
with your physician.
New patients often are so anxious
that they have trouble concentrating. Another person can help you
ask questions about treatment and
remember important information.
Having someone along with whom
you feel comfortable will make the
visit less stressful.

• Take notes or have a friend or
family member do so during
your doctor's appointment.
Having the information written
down will help you remember
important details.

• Consider tape recording
discussions with your doctor.
Recording allows you to replay
the information later to make sure
you understand it. (Ask the doctor's
permission to record first.)

• If you don't understand something
your doctor tells you, keep asking
questions until you do.
No question that is important to
you is "too embarrassing" or "too
stupid" to ask. "Knowledgeable,
active patients are more likely to
do well and less likely to get
severely depressed than passive

ones," wrote Dr. Harold Glucksburg
in Cancer Care: A Personal Guide.
"They can," he said, "become
active participants in their care
and active partners with their
physicians, rather than remaining
passive consumers."

• Offer information about yourself.
It is helpful for your doctor to
know your family's history of
cancer and any special stresses or
problems you're encountering.
Tell your doctor how much you
know about cancer and how much
you would like to participate in
decisions about your treatment.
Some patients want to know every
detail about their illness; others
prefer not to know everything and
to leave the decision making to
the doctor. Let your doctors and
your family know how much
information you want.

• If you have an important question
you want to discuss at length, let
your physician know in advance
so an appointment-either in
person or on the phone-can be
scheduled.
It might also be a good idea to
give the doctor's nurse a list of
questions in advance so the doctor
can consider them before talking
to you.

• Don't ask your doctor "leading"
questions, which can result in
incomplete or inaccurate answers.
The National Coalition for Cancer
Survivorship's publication "Team-

work: The Cancer Patient's Guide
to Talking With Your Doctor"
defines a leading question as one
which is asked in a way that signals
the answer you're hoping for. It
suggests that instead of saying,
for instance, "I'm going to be all
right, aren't I?" you instead ask,
''What do you think my prognosis
is?" Instead of asking, "Have you
done a lot of these operations?"
ask "How many of these operations have you done in the last
year?"

• Investigate other methods of
communicating with your doctor.
In a recent issue of Annals of
Internal Medicine, Drs. Kenneth
Mandi, Isaac Kohane, and Allan
Brandt wrote that E-mail could be
an ideal means for doctors to
answer patients' questions and
relay simple advice. If this method
would be good for you, see if your
doctor is open to communicating
with you in this way.

For more information, contact
your physician or contact the
M. D. Anderson Information Line:

(f)

(800) 392-1611 within
the United States, or

(f)

(713) 792-6161 outside
the United States.
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Liaison Program Strives
to Enhance Access

The University of Texas
M. D. Anderson Cancer Center

Lewis Foxhall, M.D.
Associate Vice President for Health Policy
M. D. Anderson has
long had a tradition
of extending a hand
to community
physicians. urtured under Drs.
Joseph Painter and
Joseph Ainsworth,
Referral Relations,
the multifaceted
program that I
codirect, functions as a liaison between
the institution and referring physicians.
The liaison program was created to
provide ready acce to M. D. Anderson
and to its operations. Physicians who
refer patients here know the care will
be provided by a competent and welltrained faculty. They can consult Referral
Relations' Guidefor Referring Physicians
to identify the clinical expertise of the
physicians, to find clinical protocols, or
to learn more about the multidisciplinary
treatment planning approach M. D.
Anderson practices.
Carrying that message to the field
are rep re sen tatives from the Office of
Referral Relations who meet face-to-face
with more than 2,000 physicians annually
in their offices- not ours- to better
understand their interests and concerns
and to communicate ways M. D. Anderson can serve them and their patients.
This introduction often grows into an
association that helps physicians find
appropriate, compassionate care for
8 I MD Anderson OncoLog
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